Home
About
Overview
Sharing Data
ORCID
Help
History (3)
A phase II study of depsipeptide in refractory metastatic renal cell cancer.
Molecular Weight
Occupational Injuries
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A phase II study of depsipeptide in refractory metastatic renal cell cancer.
A phase II study of depsipeptide in refractory metastatic renal cell cancer. Clin Genitourin Cancer. 2006 Jun; 5(1):57-60.
View in:
PubMed
subject areas
Adult
Aged
Antibiotics, Antineoplastic
Carcinoma, Renal Cell
Depsipeptides
Drug Administration Schedule
Female
Humans
Infusions, Intravenous
Kidney Neoplasms
Male
Middle Aged
Treatment Failure